Announced Mon, 14 Sept, 2026 · 20:25 IST
AGM results: all 3 resolutions passed including preferential equity allotment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹339.90
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+1.9+4.0+6.0+3.9+2.4+13.3———
Up moveDown movePending
AI summary
Aptus Pharma's 16th AGM on Sept 14, 2026 saw all 3 resolutions pass with 100 percent votes in favour (1,39,38,000 total, zero against). Resolutions covered adoption of FY26 audited financials, re-appointment of director Chetan Shantilal Lalseta (retiring by rotation), and approval of preferential allotment of equity shares. Promoters polled 1.25 crore shares, public non-institutions 14.38 lakh.
Likely market impact
Preferential equity allotment may dilute existing shareholdings; watch for allotment size and pricing in next filings.